Presented for research literature review only Tomer Y et al
The semaglutide and tirzepatide trials changed that expectation: Semaglutide 2.4 mg once weekly produced average weight loss around 15% at ~68 weeks in adults without diabetes, with a substantial fraction of participants losing 1520% of baseline weight
Look for one with pre-activated forms of B vitamins such as methyl-folate, methyl-cobalamin (B12), Pyridoxal-5-Phosphate form of B6, and Riboflavin-5-phosphate form of vitamin B2
The drug was originally approved for adults with obesity in June 2021
Weve linked the resources we mentioned and more on todays topic right in the show notes
[12] Insufficient stomach acid : This can affect the nutrient absorption of all of the above cofactors, as well as carnitine itself, and low stomach acid is very commonly found with Hashimotos